Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
University of California, San Francisco | San Francisco, California | United States | about 2 months ago
who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community made of people with many skills and talents. We seek candidates
-
studying circuit disassembly, plasticity, and reassembly in non-human primate and human glaucoma tissue, and the integration of stem cell-derived retinal ganglion cells into diseased retina. Highly motivated
-
to identify candidate disease-causing variants. You will develop model systems, e.g. genome-editing of immune or induced pluripotent stem cells (iPSC) with specific patient-derived genetic variants. We aim
-
Duties Outlined Provide medical care for both outpatient clinic and hospitalized patients with leukemia and hematologic malignancies (excluding stem cell transplant) Participate in the divisional on-call
-
sensing Precision biomolecule processing for single-molecule technologies 3D tissue engineering with stem cells Synthetic and hybrid tissue engineering Versatile nanopore devices for sensing, sequencing
-
Skills/Qualifications Experience in: 1) Mammalian or human stem cell culture techniques; 2) cell culture in bioreactor; 3) analytics for characterization of cells (flow cytometry, immunofluorescence
-
the teaching and research in the area of biomedical sciences, with focuses on precision oncology, stem cell and development, aging, neural and metabolism disorders and infectious diseases, biomedical imaging
-
instability in human stem cells, disease, and cancer, using human pluripotent stem cells and targeted differentiation approaches as a primary working model. Our goal is to determine how DNA and RNA instability
-
Immunogenetics (ACHI) Diplomate status and qualify as Laboratory Director accredited by ASHI for the following Areas: Hematopoietic Stem Cell/Bone Marrow Transplantation, Solid Organ Transplantation and
-
., Alzheimer’s or Parkinson’s) and a track record of first author publications, a plus. Experience with the development and validation of advanced cellular models, such as induced pluripotent stem cell–derived